We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+3.53%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.33%
AUM
$12B
AUM Growth
-$353M
Cap. Flow
-$617M
Cap. Flow %
-5.16%
Top 10 Hldgs %
12.46%
Holding
637
New
171
Increased
105
Reduced
150
Closed
191

Top Buys

Rank Stock Value
1
DAL icon
Delta Air Lines
DAL
+$140M
2
ABBV icon
AbbVie
ABBV
+$119M
3
KEY icon
KeyCorp
KEY
+$115M
4
FFIV icon
F5
FFIV
+$111M
5
WMT icon
Walmart Inc
WMT
+$110M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$146M
2
SPGI icon
S&P Global
SPGI
+$142M
3
LLY icon
Eli Lilly
LLY
+$133M
4
LH icon
Labcorp
LH
+$131M
5
RHT
Red Hat Inc
RHT
+$121M

Sector Composition

Rank Sector Weight
1 Technology 17.86%
2 Healthcare 13.19%
3 Industrials 12.91%
4 Consumer Discretionary 10.27%
5 Financials 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPGI icon
251
S&P Global
SPGI
$121B
$8.54M 0.07%
58,471
-1,021,857
-95% -$142M
CHRS icon
252
Coherus Oncology
CHRS
$228M
$8.41M 0.07%
586,027
+136,027
+30% +$2.62M
OPTU
253
Optimum Communications Inc
OPTU
$313M
$8.07M 0.07%
+250,000
New +$8.27M
HYG icon
254
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
$7.96M 0.07%
90,000
+5,000
+6% +$440K
GNMK
255
DELISTED
GenMark Diagnostics, Inc
GNMK
$7.86M 0.07%
664,062
+486,627
+274% +$6.22M
APEI icon
256
American Public Education
APEI
$985M
$7.78M 0.07%
328,844
-9,966
-3% -$228K
INVH icon
257
Invitation Homes
INVH
$18B
$7.73M 0.06%
357,524
-319,924
-47% -$6.89M
EACQ
258
CALL
DELISTED
Easterly Acquisition Corp
EACQ
$7.66M 0.06%
761,707
– –
FG
259
CALL
DELISTED
FGL Holdings Ordinary Shares
FG
$7.59M 0.06%
675,000
– –
FN icon
260
Fabrinet
FN
$19B
$7.54M 0.06%
176,812
-365,086
-67% -$13.7M
GOLF icon
261
Acushnet Holdings
GOLF
$6B
$7.44M 0.06%
375,000
-575,000
-61% -$10.8M
WPM icon
262
Wheaton Precious Metals
WPM
$55.7B
$7.41M 0.06%
372,635
+230,787
+163% +$4.72M
SGYP
263
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$7.38M 0.06%
1,658,770
-50,265
-3% -$207K
CVLT icon
264
Commault Systems
CVLT
$5.5B
$7.32M 0.06%
+129,617
New +$7.09M
SEI
265
Solaris Energy Infrastructure
SEI
$3.44B
$6.92M 0.06%
+600,000
New +$6.8M
ACRS icon
266
Aclaris Therapeutics
ACRS
$891M
$6.85M 0.06%
252,683
+59,726
+31% +$1.62M
SAGE
267
DELISTED
Sage Therapeutics
SAGE
$6.73M 0.06%
84,449
+9,449
+13% +$683K
VRRM icon
268
CALL
Verra Mobility
VRRM
$842M
$6.69M 0.06%
+666,666
New +$6.71M
LKSD
269
DELISTED
LSC Communications, Inc.
LKSD
$6.44M 0.05%
300,795
-99,205
-25% -$2.27M
PETX
270
DELISTED
Aratana Therapeutics, Inc.
PETX
$6.31M 0.05%
872,353
+722,353
+482% +$4.44M
SCWX
271
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$6.3M 0.05%
678,438
+301,008
+80% +$2.87M
JILL icon
272
J. Jill
JILL
$285M
$6.27M 0.05%
121,558
+35,544
+41% +$1.91M
SCTL
273
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$6.16M 0.05%
977,408
+138,115
+16% +$946K
HUNT
274
DELISTED
Hunter Maritime Acquisition Corp. Common Stock
HUNT
$5.93M 0.05%
+600,000
New +$5.88M
INTC icon
275
Intel
INTC
$515B
$5.85M 0.05%
+173,511
New +$6.21M
9 10
11
12 13

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM

Alyeska Investment Group's Q2 2017 Portfolio in Review

As of Q2 2017, Alyeska Investment Group held 637 positions worth $12B, down 2.9% from $12.3B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Alyeska Investment Group withdrew a net $617M in Q2 2017, closing 191 positions and reducing 150 holdings. Its most notable exit was Eli Lilly, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Alyeska Investment Group opened a new position in AbbVie worth $128M.

  • Alyeska Investment Group's largest Q2 2017 buy was AbbVie: 1,771,895 shares worth $128M.
  • Alyeska Investment Group added most to Delta Air Lines in Q2 2017, an estimated $140M increase.
  • Alyeska Investment Group's biggest Q2 2017 reduction was Oracle, cutting an estimated $146M.
  • Alyeska Investment Group fully exited Eli Lilly in Q2 2017, selling an estimated $133M.
  • Alyeska Investment Group's ten largest holdings make up 12% of its $12B portfolio in Q2 2017.
  • Alyeska Investment Group opened 171 new positions and closed 191 in Q2 2017.
  • Alyeska Investment Group's portfolio value fell 2.9% quarter-over-quarter to $12B.

Based on Alyeska Investment Group's 13F filing for Q2 2017, filed 14 Aug 2017.